[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

US2558395A - Undenatured gelatin hemostatic sponge containing thrombin - Google Patents

Undenatured gelatin hemostatic sponge containing thrombin Download PDF

Info

Publication number
US2558395A
US2558395A US17366A US1736648A US2558395A US 2558395 A US2558395 A US 2558395A US 17366 A US17366 A US 17366A US 1736648 A US1736648 A US 1736648A US 2558395 A US2558395 A US 2558395A
Authority
US
United States
Prior art keywords
thrombin
gelatin
undenatured
hemostatic sponge
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US17366A
Inventor
Andre Studer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Hoffmann La Roche Inc
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of US2558395A publication Critical patent/US2558395A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/28—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a liquid phase from a macromolecular composition or article, e.g. drying of coagulum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2389/00—Characterised by the use of proteins; Derivatives thereof

Definitions

  • the present invention relates to a process for the manufacture of hemostatic tampons and bandages.
  • hemostatic tampon and bandages may be prepared from undenatured water soluble gelatin by adding thrombin to an aqueous gelatin solution, transforming the solution obtained into foam and drying the foam obtained in vacuo at a low temperature.
  • the form of the thrombonic gelatin sponge may be adapted to the requirements of the intended use.
  • the present process yields hemostatic tampons and bandages consisting of an easily soluble mass of gelatin and thrombin and which is of a cotton-wool like appearance. These tampons and bandages need not be dipped into a thrombin solution but may be placed on any wound without prior treatment.
  • the new tampons and bandages quickly cause hemostasis; the blood flowing from the Wound is absorbed into the sponge, thereby dissolving the gelatin component; the thrombin which is thus released immediately causes the transformation of fibrinogen into fibrin. A fibrin film is thus formed over the wound, whereby the latter is closed and the flow of the blood is stopped. The film clings tightly to the surface of the wound, in many cases rendering the use of bandages or like means of protection unneces-
  • the efiiciency of the tampons manufactured in accordance with the present invention may be demonstrated in vitro by the following experiment: .In a test tube (about 1 cm. internal diameterl a few tampons are loosely stamped to form a column about 5 cm. high. 5 com. of plasma of 37 C. are poured thereon. The plasma issucked into the sponge-like material and coagulates so quickly that the test tube may be turned upside down directly after filling in the plasma without any of the latter running out.
  • antiseptic agents may be added to the gelatin-thrombin product without influencing the activity of the tampons and bandages.
  • Thymol a mixture of p-hydroxybenzoic-acidmethyl and propylester, or sulfamides, such as 5-sulfanilamido-3,l-dimethyl-isoxazole, are :antiseptics which may be so used.
  • the addition of substances accelerating cicatrization, such as panthenol, may also be found to be useful.
  • Panthenol is the generic name for 'y-dihydroxy- 3,5 dimethyl butyric acid (3' hydroxypropyl) -amide.
  • the gelatin has a protective and stabilizing effect on the thrombin with which it is impregnated. It has been found, for instance, that the activity of an aqueous thrombin solution containing 5 per cent. gelatin falls away more slowly than in the case of such a solution containing no gelatin.
  • Th. U. stands for thrombin units (1 llh. U. being the amount of thrombin which causes 1 ccm. of plasma of bovine to coagulate within 30 seconds at a temperature of 37 0.
  • thrombin preparation showing on titration a content of 100 Th. U./mg.
  • the slightly turbid solution is passed through, a filter which retains bacteria.
  • the clear solution is transformed into a voluminous foam by blowing in sterile air through a" glass plate.
  • the froth is spread out over a sheet, frozen and dehydrated in high vacuo at low temperature.
  • Example 2 70 mg. of thymol are dissolved in 100 com. warm distilled water. grams of gelatin are added to the solution and the mixture is heated to 80 C. Further working as describedin Example 1.
  • Example 3 20 mg. of p-hydroxybenzoylmethylester and 80 4 freeze-dried foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.
  • a preformed hemostatic sponge made by drying, at low temperature and under reduced pressure, a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.
  • Example 4 5 grams of gelatin in 90 com. distilled water are heated to 80 C. 2 grams of finely pulverised5- sulfanilamido-3,4-dimethylisoxazole are suspended in the warm solution. The solution is set to a pH of 6.6 by adding 5 to 10 com. of normal sodium hydroxide. The sulfanilamide then dissolves. The mixture is heated to 80 C. and Worked further in accordance with Example 1.
  • Example 5 0.2 gram of panthenol is dissolved in 100 com. of distilled water. 5 grams of gelatin are added. The mixture is heated to 80 C. and worked further in accordance with Example 1.
  • a preformed hemostatic sponge made by freezing a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin, and drying the frozen foam in vacuo at a low temperatur r ANDRE STUDER.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Description

Patented June 26, 1951 TUNITED' STATES PATENT OFFICE Andr Studerl...B.a seL Switzerland, assignor to Hoiimann-La Roche Inc., Nutley, N. J acorporation of New Jersey No Drawing. Application March 26, 1948, Serial No. 17,366: In SWitzerlandJune 3, 194.7
The present invention relates to a process for the manufacture of hemostatic tampons and bandages.
In surgery hemostatic tampons and bandages consisting of fibrinand"cellulose-derivative sponges which contain a, thrombin solution are used. These tampons and bandages are prepared for use by dipping them into a thrombin solution immediately priorto application. This mode of use requires the sponges to consist of a material insoluble in water, because otherwise they would collapse during the contact with the aqueous thrombin solution. 'Such sponges have the disadvantage of being resorbed much more slowly by the organism than water soluble sub stances. r
In order to avoid this disadvantage a soluble gelatine gel has been used in place of the said sponges. This gel is immersed in a thrombin solution immediately prior to application. However, it is difiicult and takes a considerable amount of time to obtain the complete impregnation of such gels by the thrombin solution. Furthermore, such impregnated tampons cannot be stored because the thrombin is unstable in the presence of water and its activity quickly diminishes. Again it has been found that thrombin brings about a diminution of the jellifying quality of the gelatin.
It has now been found, according to the present invention, that hemostatic tampon and bandages may be prepared from undenatured water soluble gelatin by adding thrombin to an aqueous gelatin solution, transforming the solution obtained into foam and drying the foam obtained in vacuo at a low temperature. The form of the thrombonic gelatin sponge may be adapted to the requirements of the intended use. The present process yields hemostatic tampons and bandages consisting of an easily soluble mass of gelatin and thrombin and which is of a cotton-wool like appearance. These tampons and bandages need not be dipped into a thrombin solution but may be placed on any wound without prior treatment. The new tampons and bandages quickly cause hemostasis; the blood flowing from the Wound is absorbed into the sponge, thereby dissolving the gelatin component; the thrombin which is thus released immediately causes the transformation of fibrinogen into fibrin. A fibrin film is thus formed over the wound, whereby the latter is closed and the flow of the blood is stopped. The film clings tightly to the surface of the wound, in many cases rendering the use of bandages or like means of protection unneces- The efiiciency of the tampons manufactured in accordance with the present invention may be demonstrated in vitro by the following experiment: .In a test tube (about 1 cm. internal diameterl a few tampons are loosely stamped to form a column about 5 cm. high. 5 com. of plasma of 37 C. are poured thereon. The plasma issucked into the sponge-like material and coagulates so quickly that the test tube may be turned upside down directly after filling in the plasma without any of the latter running out.
If so desired antiseptic agents may be added to the gelatin-thrombin product without influencing the activity of the tampons and bandages. Thymol, a mixture of p-hydroxybenzoic-acidmethyl and propylester, or sulfamides, such as 5-sulfanilamido-3,l-dimethyl-isoxazole, are :antiseptics which may be so used. The addition of substances accelerating cicatrization, such as panthenol, may also be found to be useful. Panthenol is the generic name for 'y-dihydroxy- 3,5 dimethyl butyric acid (3' hydroxypropyl) -amide.
The gelatin has a protective and stabilizing effect on the thrombin with which it is impregnated. It has been found, for instance, that the activity of an aqueous thrombin solution containing 5 per cent. gelatin falls away more slowly than in the case of such a solution containing no gelatin. The following table in which Th. U. stands for thrombin units (1 llh. U. being the amount of thrombin which causes 1 ccm. of plasma of bovine to coagulate within 30 seconds at a temperature of 37 0.), illustrates this fact:
5 grams of gelatin in sheets are added to 100 com. of distilled water. The mixture is heated to C. and filtered while still warm through a filter which retains bacteria. The filtrate is adjusted to a pH of 6.6. 10 com. of a thrombin solution containing 10,000 units per com. (vide supra) are added to 50 com. of the filtrate which ha been cooled down to a temperature of 20 C. (This thrombin solution may be prepared from a,
thrombin preparation showing on titration a content of 100 Th. U./mg.) The slightly turbid solution is passed through, a filter which retains bacteria. The clear solution is transformed into a voluminous foam by blowing in sterile air through a" glass plate. The froth is spread out over a sheet, frozen and dehydrated in high vacuo at low temperature.'
Example 2 70 mg. of thymol are dissolved in 100 com. warm distilled water. grams of gelatin are added to the solution and the mixture is heated to 80 C. Further working as describedin Example 1.
Example 3 20 mg. of p-hydroxybenzoylmethylester and 80 4 freeze-dried foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.
2. A preformed hemostatic sponge made by drying, at low temperature and under reduced pressure, a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin.
mg. of p-hydroxybenzoylpropylester are dissolved in 100 ccm. of distilled water. 5 mg. of gelatin are added and the mixture is heated to 80 C. Further working as described in Example 1.
Example 4 5 grams of gelatin in 90 com. distilled water are heated to 80 C. 2 grams of finely pulverised5- sulfanilamido-3,4-dimethylisoxazole are suspended in the warm solution. The solution is set to a pH of 6.6 by adding 5 to 10 com. of normal sodium hydroxide. The sulfanilamide then dissolves. The mixture is heated to 80 C. and Worked further in accordance with Example 1.
Example 5 0.2 gram of panthenol is dissolved in 100 com. of distilled water. 5 grams of gelatin are added. The mixture is heated to 80 C. and worked further in accordance with Example 1.
I claim:
1. As a ready-to-use hemostatic sponge, a
3. A preformed hemostatic sponge made by freezing a foam of an aqueous solution containing undenatured water-soluble gelatin and thrombin, and drying the frozen foam in vacuo at a low temperatur r ANDRE STUDER.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number .Name Date 2,166,074 Reichel July 11, 1939 2,398,077 Smith Apr. 9, 1946 FOREIGN PATENTS Number Country 7 Date 474,093 Germany Mar. 26, 1929 OTHER REFERENCES Lesser, Drug and Cosmetic Industry, March,
' 1947, page 329.
Bing, Acta Pharmacol, 1947, vol. 3, page 366.
American Druggist, October, 1947, pages 9 96 and 16 8.
Correll et al., Proc. Soc. Exper. Biol.- and Medicine, 58, 233-5, March, 1945.
Bering, J. Clinical Investigation No. 4, 1944, pages 586-590.

Claims (1)

1. AS A READY-TO-USE HEMOSTATIC SPONGE, A FREEZE-DRIED FOAM OF AN AQUEOUS SOLUTION CONTAINING UNDENATURED WATER-SOLUBLE GELATIN AND THROMBIN.
US17366A 1947-06-03 1948-03-26 Undenatured gelatin hemostatic sponge containing thrombin Expired - Lifetime US2558395A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH2350347A CH264752A (en) 1947-06-03 1947-06-03 Process for the manufacture of carriers for pharmaceuticals.

Publications (1)

Publication Number Publication Date
US2558395A true US2558395A (en) 1951-06-26

Family

ID=38468378

Family Applications (1)

Application Number Title Priority Date Filing Date
US17366A Expired - Lifetime US2558395A (en) 1947-06-03 1948-03-26 Undenatured gelatin hemostatic sponge containing thrombin

Country Status (6)

Country Link
US (1) US2558395A (en)
AT (1) AT165549B (en)
CH (1) CH264752A (en)
DE (1) DE915973C (en)
DK (1) DK73956C (en)
ES (1) ES183694A1 (en)

Cited By (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2642375A (en) * 1951-08-21 1953-06-16 Ethicon Suture Lab Inc Hemostatic compositions
US2712672A (en) * 1952-01-28 1955-07-12 Calcagno Luigi Process for preparing proteic sponges
US2718487A (en) * 1950-12-18 1955-09-20 Hoechst Ag Hemostatics containing reaction products of thrombin and acridines and process of preparing same
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
US4341207A (en) * 1979-09-07 1982-07-27 Kingsdown Medical Consultants Limited Wound dressing
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
US5039414A (en) * 1989-08-01 1991-08-13 Mueller Marc B Process for separating and/or recovering hydrocarbon oils from water using biodegradable absorbent sponges
US5149540A (en) * 1990-03-01 1992-09-22 Mochida Pharmaceutical Co., Ltd. Thrombin composition for oral administration
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6162192A (en) * 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US6261679B1 (en) 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20020156495A1 (en) * 1995-09-15 2002-10-24 Rodney Brenneman Apparatus and method for percutaneous sealing of blood vessel punctures
US20020190226A1 (en) * 2001-03-12 2002-12-19 Mark Ashby Methods for sterilizing cross-linked gelatin compositions
US20020193448A1 (en) * 1996-08-27 2002-12-19 Wallace Donald G. Fragmented polymeric compositions and methods for their use
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20030064109A1 (en) * 2001-07-17 2003-04-03 Zhen Qian Dry hemostatic compositions and methods for their preparation
US6544236B1 (en) 1999-02-10 2003-04-08 Sub-Q, Incorporated Device, system and method for improving delivery of hemostatic material
US20030155679A1 (en) * 2001-12-31 2003-08-21 Reeves William G. Method of making regenerated carbohydrate foam compositions
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US20040019330A1 (en) * 2001-11-08 2004-01-29 Sub-Q, Inc., A California Corporation Sheath based blood vessel puncture locator and depth indicator
US20040102730A1 (en) * 2002-10-22 2004-05-27 Davis Thomas P. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20040158287A1 (en) * 2000-07-14 2004-08-12 Cragg Andrew H. Sheath-mounted arterial plug delivery device
US20040176723A1 (en) * 2001-11-08 2004-09-09 Sing Eduardo Chi Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6846320B2 (en) 1998-05-01 2005-01-25 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US20050033360A1 (en) * 2001-11-08 2005-02-10 Sing Eduardo Chi Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6863680B2 (en) 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
EP1572004A2 (en) * 2002-11-04 2005-09-14 Sub Q, Inc. Apparatus and method for inhibiting blood loss
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US20060115805A1 (en) * 2002-12-11 2006-06-01 Hansen John E Gelatine-based materials as swabs
US20060167561A1 (en) * 2003-06-05 2006-07-27 Johann Odar Methods for repairing and regenerating human dura mater
US20070009578A1 (en) * 2004-07-09 2007-01-11 Lene Moller Haemostatic composition comprising hyaluronic acid
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
US20070160543A1 (en) * 2004-01-30 2007-07-12 Lene Moller Haemostatic sprays and compositions
US20080076722A1 (en) * 2006-09-27 2008-03-27 Hemostasis, Llc Hemostatic Agent and Method
US20080085316A1 (en) * 1996-08-27 2008-04-10 Baxter Healthcare Corporation Dry hemostatic compositions and methods for their preparation
US20080187591A1 (en) * 2006-08-02 2008-08-07 Baxter International, Inc. Rapidly acting dry sealant and methods for use and manufacture
US20090226391A1 (en) * 2008-03-04 2009-09-10 Hemostasis, Llc Hemostatic Sponge and Method of Manufacture
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
US20100028309A1 (en) * 2006-05-31 2010-02-04 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US20100183582A1 (en) * 2003-08-07 2010-07-22 Ethicon, Inc. Hemostatic compositions containing sterile thrombin
US20100292717A1 (en) * 2009-05-18 2010-11-18 Baxter International Inc. Method for the improvement of mesh implant biocompatibility
US20100318048A1 (en) * 2009-06-16 2010-12-16 Baxter International Inc. Hemostatic sponge
US20110014290A1 (en) * 1995-09-15 2011-01-20 Boston Scientific Scimed, Inc. System and method for facilitating hemostasis with an absorbable sponge
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
US20110021964A1 (en) * 2008-02-29 2011-01-27 Ferrosan Medical Devices A/S Device for Promotion of Hemostasis and/or Wound Healing
US20110045034A1 (en) * 2008-03-03 2011-02-24 Israel Nur Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US20110202026A1 (en) * 2009-12-16 2011-08-18 Baxter International Inc. Hemostatic sponge
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
US20130096062A1 (en) * 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US8703170B2 (en) 2010-04-07 2014-04-22 Baxter International Inc. Hemostatic sponge
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9084728B2 (en) 2010-06-01 2015-07-21 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9408945B2 (en) 2010-06-01 2016-08-09 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US9821025B2 (en) 2011-10-11 2017-11-21 Baxter International Inc. Hemostatic compositions
US9833541B2 (en) 2011-10-27 2017-12-05 Baxter International Inc. Hemostatic compositions
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CN109789091A (en) * 2016-09-14 2019-05-21 奥姆里克斯生物药品有限公司 Stable pharmaceutical foam
US10322170B2 (en) 2011-10-11 2019-06-18 Baxter International Inc. Hemostatic compositions
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US11123397B2 (en) * 2016-09-14 2021-09-21 Omrix Biopharmaceuticals Ltd. Stable pharmaceutical foam
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2702356A1 (en) * 1977-01-21 1978-07-27 Gottlieb Sheldon K Repairing depressed cutaneous scars - using fibrin stabiliser and plasma
DE4001714A1 (en) * 1990-01-22 1991-07-25 Beiersdorf Ag SELF-ADHESIVE BASED ON GELATINE

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE474093C (en) * 1927-07-30 1929-03-26 Erich Freund Dr Process for the production of hemostatic and wound-healing bandages and plasters
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
US2398077A (en) * 1940-04-29 1946-04-09 Parke Davis & Co Blood coagulating product and method of obtaining same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE474093C (en) * 1927-07-30 1929-03-26 Erich Freund Dr Process for the production of hemostatic and wound-healing bandages and plasters
US2166074A (en) * 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
US2398077A (en) * 1940-04-29 1946-04-09 Parke Davis & Co Blood coagulating product and method of obtaining same

Cited By (165)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2718487A (en) * 1950-12-18 1955-09-20 Hoechst Ag Hemostatics containing reaction products of thrombin and acridines and process of preparing same
US2642375A (en) * 1951-08-21 1953-06-16 Ethicon Suture Lab Inc Hemostatic compositions
US2712672A (en) * 1952-01-28 1955-07-12 Calcagno Luigi Process for preparing proteic sponges
US3234091A (en) * 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
US4006220A (en) * 1975-06-04 1977-02-01 Gottlieb Sheldon K Compositions and methods useful for repairing depressed cutaneous scars
US4341207A (en) * 1979-09-07 1982-07-27 Kingsdown Medical Consultants Limited Wound dressing
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
EP0044624A1 (en) * 1980-07-09 1982-01-27 E.R. Squibb & Sons, Inc. Lyophilized hydrocolloid foam
US4538603A (en) * 1982-04-22 1985-09-03 E. R. Squibb & Sons, Inc. Dressings, granules, and their use in treating wounds
US5039414A (en) * 1989-08-01 1991-08-13 Mueller Marc B Process for separating and/or recovering hydrocarbon oils from water using biodegradable absorbent sponges
US5149540A (en) * 1990-03-01 1992-09-22 Mochida Pharmaceutical Co., Ltd. Thrombin composition for oral administration
US7175646B2 (en) 1995-09-15 2007-02-13 Boston Scientific Scimed, Inc. Apparatus and method for percutaneous sealing of blood vessel punctures
US20110014290A1 (en) * 1995-09-15 2011-01-20 Boston Scientific Scimed, Inc. System and method for facilitating hemostasis with an absorbable sponge
US20020156495A1 (en) * 1995-09-15 2002-10-24 Rodney Brenneman Apparatus and method for percutaneous sealing of blood vessel punctures
US20080085316A1 (en) * 1996-08-27 2008-04-10 Baxter Healthcare Corporation Dry hemostatic compositions and methods for their preparation
US7871637B2 (en) 1996-08-27 2011-01-18 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8357378B2 (en) 1996-08-27 2013-01-22 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US8512729B2 (en) 1996-08-27 2013-08-20 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US20020193448A1 (en) * 1996-08-27 2002-12-19 Wallace Donald G. Fragmented polymeric compositions and methods for their use
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6440153B2 (en) 1998-05-01 2002-08-27 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US20050113737A1 (en) * 1998-05-01 2005-05-26 Mark Ashby Device and method for facilitating hemostasis of a biopsy tract
US6527734B2 (en) 1998-05-01 2003-03-04 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US8050741B2 (en) 1998-05-01 2011-11-01 Boston Scientific Scimed, Inc. Device and method for facilitating hemostasis of a biopsy tract
US7618567B2 (en) 1998-05-01 2009-11-17 Boston Scientific Scimed, Inc. Absorbable sponge with contrasting agent
US6200328B1 (en) 1998-05-01 2001-03-13 Sub Q, Incorporated Device and method for facilitating hemostasis of a biopsy tract
US20030088271A1 (en) * 1998-05-01 2003-05-08 Cragg Andrew M. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20030135237A1 (en) * 1998-05-01 2003-07-17 Cragg Andrew H. Device, system and method for improving delivery of hemostatic material
US6315753B1 (en) 1998-05-01 2001-11-13 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7611479B2 (en) 1998-05-01 2009-11-03 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6610026B2 (en) 1998-05-01 2003-08-26 Sub-Q, Inc. Method of hydrating a sponge material for delivery to a body
US6183497B1 (en) 1998-05-01 2001-02-06 Sub-Q, Inc. Absorbable sponge with contrasting agent
US7625352B1 (en) 1998-05-01 2009-12-01 Sub-Q, Inc. Depth and puncture control for system for hemostasis of blood vessel
US20100029908A1 (en) * 1998-05-01 2010-02-04 Boston Scientific Scimed, Inc. Absorbable sponge with contrasting agent
US6447534B2 (en) 1998-05-01 2002-09-10 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US20100036414A1 (en) * 1998-05-01 2010-02-11 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6071301A (en) * 1998-05-01 2000-06-06 Sub Q., Inc. Device and method for facilitating hemostasis of a biopsy tract
US6846320B2 (en) 1998-05-01 2005-01-25 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US6162192A (en) * 1998-05-01 2000-12-19 Sub Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US7753872B2 (en) 1998-05-01 2010-07-13 Boston Scientific Scimed, Inc. Device, system and method for improving delivery of hemostatic material
US6440151B1 (en) 1998-05-01 2002-08-27 Sub-Q, Inc. Device and method for facilitating hemostasis of a biopsy tract
US20050059080A1 (en) * 1998-05-01 2005-03-17 Sing Eduardo Chi Absorbable sponge with contrasting agent
US7048710B1 (en) 1998-05-01 2006-05-23 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20030220039A1 (en) * 1998-05-22 2003-11-27 Fung-Jou Chen Fibrous absorbent material and methods of making the same
US6603054B2 (en) 1998-05-22 2003-08-05 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US6261679B1 (en) 1998-05-22 2001-07-17 Kimberly-Clark Worldwide, Inc. Fibrous absorbent material and methods of making the same
US6544236B1 (en) 1999-02-10 2003-04-08 Sub-Q, Incorporated Device, system and method for improving delivery of hemostatic material
US7695492B1 (en) 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US6984219B2 (en) 1999-09-23 2006-01-10 Mark Ashby Depth and puncture control for blood vessel hemostasis system
US6964658B2 (en) 2000-05-12 2005-11-15 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US6540735B1 (en) 2000-05-12 2003-04-01 Sub-Q, Inc. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US20040158287A1 (en) * 2000-07-14 2004-08-12 Cragg Andrew H. Sheath-mounted arterial plug delivery device
US8696702B2 (en) 2000-07-14 2014-04-15 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US7621936B2 (en) 2000-07-14 2009-11-24 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US20100049245A1 (en) * 2000-07-14 2010-02-25 Boston Scientific Scimed, Inc. Sheath-mounted arterial plug delivery device
US7201725B1 (en) 2000-09-25 2007-04-10 Sub-Q, Inc. Device and method for determining a depth of an incision
US6849232B2 (en) 2001-03-12 2005-02-01 Sub-Q, Inc. Methods for sterilizing cross-linked gelatin compositions
US8187625B2 (en) 2001-03-12 2012-05-29 Boston Scientific Scimed, Inc. Cross-linked gelatin composition comprising a wetting agent
US8821918B2 (en) 2001-03-12 2014-09-02 Boston Scientific Scimed Inc. Cross-linked gelatin composition comprising a wetting agent
US20020190226A1 (en) * 2001-03-12 2002-12-19 Mark Ashby Methods for sterilizing cross-linked gelatin compositions
US8524270B2 (en) 2001-03-12 2013-09-03 Boston Scientific Scimed, Inc. Cross-linked gelatin composition coated with a wetting agent
US7264772B2 (en) 2001-03-12 2007-09-04 Boston Scientific Scimed, Inc. Methods for sterilizing cross-linked gelatin compositions
US7029489B1 (en) 2001-05-18 2006-04-18 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site
US20070248685A1 (en) * 2001-07-17 2007-10-25 Fusion Medical Technologies, Inc. Dry hemostatic compositions and methods for their preparation
US8092820B2 (en) 2001-07-17 2012-01-10 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
AU2002345846B2 (en) * 2001-07-17 2007-08-23 Baxter Healthcare S.A. Dry hemostatic compositions and methods for their preparation
EP1803417A1 (en) * 2001-07-17 2007-07-04 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US20080286376A1 (en) * 2001-07-17 2008-11-20 Fusion Medical Technologies, Inc. Dry hemostatic compositions and methods for their preparation
US7547446B2 (en) 2001-07-17 2009-06-16 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
EP1414370A1 (en) * 2001-07-17 2004-05-06 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US8383141B2 (en) 2001-07-17 2013-02-26 Baxter International Inc. Dry hemostatic compositions and methods for their preparation
US20090227779A1 (en) * 2001-07-17 2009-09-10 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
EP1414370A4 (en) * 2001-07-17 2005-11-09 Baxter Int Dry hemostatic compositions and methods for their preparation
US20030064109A1 (en) * 2001-07-17 2003-04-03 Zhen Qian Dry hemostatic compositions and methods for their preparation
US20050033360A1 (en) * 2001-11-08 2005-02-10 Sing Eduardo Chi Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US20040176723A1 (en) * 2001-11-08 2004-09-09 Sing Eduardo Chi Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US6863680B2 (en) 2001-11-08 2005-03-08 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7008440B2 (en) 2001-11-08 2006-03-07 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US20040019330A1 (en) * 2001-11-08 2004-01-29 Sub-Q, Inc., A California Corporation Sheath based blood vessel puncture locator and depth indicator
US7037322B1 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. System and method for delivering hemostasis promoting material to a blood vessel puncture with a staging tube
US7192436B2 (en) 2001-11-08 2007-03-20 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US7037323B2 (en) 2001-11-08 2006-05-02 Sub-Q, Inc. Pledget-handling system and method for delivering hemostasis promoting material to a blood vessel puncture site by fluid pressure
US8283320B2 (en) 2001-12-21 2012-10-09 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostasis
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
US20030155679A1 (en) * 2001-12-31 2003-08-21 Reeves William G. Method of making regenerated carbohydrate foam compositions
US20040102730A1 (en) * 2002-10-22 2004-05-27 Davis Thomas P. System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge
US8317821B1 (en) 2002-11-04 2012-11-27 Boston Scientific Scimed, Inc. Release mechanism
EP1572004A2 (en) * 2002-11-04 2005-09-14 Sub Q, Inc. Apparatus and method for inhibiting blood loss
EP1572004A4 (en) * 2002-11-04 2009-07-01 Sub Q Inc Apparatus and method for inhibiting blood loss
US7335219B1 (en) 2002-11-04 2008-02-26 Sub-Q, Inc. Hemostatic device including a capsule
US7955353B1 (en) 2002-11-04 2011-06-07 Sub-Q, Inc. Dissolvable closure device
US20060115805A1 (en) * 2002-12-11 2006-06-01 Hansen John E Gelatine-based materials as swabs
US7955288B2 (en) 2002-12-11 2011-06-07 Ferrosan Medical Devices A/S Gelatine-based materials as swabs
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US20060167561A1 (en) * 2003-06-05 2006-07-27 Johann Odar Methods for repairing and regenerating human dura mater
US20100183582A1 (en) * 2003-08-07 2010-07-22 Ethicon, Inc. Hemostatic compositions containing sterile thrombin
US9005609B2 (en) 2003-08-07 2015-04-14 Ethicon, Inc. Hemostatic compositions containing sterile thrombin
US7875043B1 (en) 2003-12-09 2011-01-25 Sub-Q, Inc. Cinching loop
US7923031B2 (en) 2004-01-30 2011-04-12 Ferrosan Medical Devices A/S Haemostatic sprays and compositions
US20070160543A1 (en) * 2004-01-30 2007-07-12 Lene Moller Haemostatic sprays and compositions
US8021684B2 (en) 2004-07-09 2011-09-20 Ferrosan Medical Devices A/S Haemostatic composition comprising hyaluronic acid
US20070009578A1 (en) * 2004-07-09 2007-01-11 Lene Moller Haemostatic composition comprising hyaluronic acid
US8703122B2 (en) 2006-05-31 2014-04-22 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
US20100028309A1 (en) * 2006-05-31 2010-02-04 Baxter International Inc. Method for directed cell in-growth and controlled tissue regeneration in spinal surgery
US8962025B2 (en) 2006-08-02 2015-02-24 Baxter International Inc. Rapidly acting dry sealant and methods for use and manufacture
US20080187591A1 (en) * 2006-08-02 2008-08-07 Baxter International, Inc. Rapidly acting dry sealant and methods for use and manufacture
US9114172B2 (en) 2006-08-02 2015-08-25 Baxter International Inc. Rapidly acting dry sealant and methods for use and manufacture
US9649482B2 (en) 2006-09-27 2017-05-16 Hemostasis, Llc Hemostatic agent and method
US10744310B2 (en) 2006-09-27 2020-08-18 Hemostasis, Llc Hemostatic agent and method
US8623842B2 (en) 2006-09-27 2014-01-07 Hemostasis, Llc Hemostatic agent and method
US20080076722A1 (en) * 2006-09-27 2008-03-27 Hemostasis, Llc Hemostatic Agent and Method
US8790698B2 (en) 2007-10-30 2014-07-29 Baxter International Inc. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
US20110021964A1 (en) * 2008-02-29 2011-01-27 Ferrosan Medical Devices A/S Device for Promotion of Hemostasis and/or Wound Healing
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US20110045034A1 (en) * 2008-03-03 2011-02-24 Israel Nur Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use
US8981058B2 (en) 2008-03-03 2015-03-17 Omrix Biopharmaceuticals Ltd. Gelatin sponge comprising an active ingredient, its preparation and use
US9427490B2 (en) 2008-03-03 2016-08-30 Omrix Biopharmaceuticals Ltd. Gelatin sponge comprising an active ingredient, its preparation and use
US8475812B2 (en) 2008-03-03 2013-07-02 Omrix Biopharmaceuticals Ltd. Gelatin sponge comprising an active ingredient, its preparation and use
US20090226391A1 (en) * 2008-03-04 2009-09-10 Hemostasis, Llc Hemostatic Sponge and Method of Manufacture
US9061087B2 (en) 2008-03-04 2015-06-23 Hemostasis, Llc Method of making a hemostatic sponge wound dressing comprising subjecting the sponge to water vapor
US20100292717A1 (en) * 2009-05-18 2010-11-18 Baxter International Inc. Method for the improvement of mesh implant biocompatibility
US9993298B2 (en) 2009-05-18 2018-06-12 Baxter International Inc. Method for the improvement of mesh implant biocompatibility
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
US20100318048A1 (en) * 2009-06-16 2010-12-16 Baxter International Inc. Hemostatic sponge
US20110052663A1 (en) * 2009-09-01 2011-03-03 Hemostasis, Llc Hemostatic Sponge with Enzyme and Method of Manufacture
US9517287B2 (en) 2009-12-16 2016-12-13 Baxter International, Inc. Hemostatic sponge
US9872934B2 (en) 2009-12-16 2018-01-23 Baxter International Inc. Hemostatic sponge
US20110202026A1 (en) * 2009-12-16 2011-08-18 Baxter International Inc. Hemostatic sponge
US11071804B2 (en) 2009-12-16 2021-07-27 Baxter International Inc. Hemostatic sponge
US8771258B2 (en) 2009-12-16 2014-07-08 Baxter International Inc. Hemostatic sponge
US9375505B2 (en) 2010-04-07 2016-06-28 Baxter International Inc. Hemostatic sponge
US10441674B2 (en) 2010-04-07 2019-10-15 Baxter International Inc. Hemostatic sponge
US11478566B2 (en) 2010-04-07 2022-10-25 Baxter International Inc. Hemostatic sponge
US8703170B2 (en) 2010-04-07 2014-04-22 Baxter International Inc. Hemostatic sponge
EP2575775B1 (en) 2010-06-01 2018-04-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9084728B2 (en) 2010-06-01 2015-07-21 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9408945B2 (en) 2010-06-01 2016-08-09 Baxter International Inc. Process for making dry and stable hemostatic compositions
EP2575776B1 (en) 2010-06-01 2018-05-30 Baxter International Inc Process for making dry and stable hemostatic compositions
EP2575770B1 (en) 2010-06-01 2017-03-22 Baxter International Inc Process for making dry and stable hemostatic compositions
US10994045B2 (en) 2010-06-01 2021-05-04 Baxter International Inc. Process for making dry and stable hemostatic compositions
US8940335B2 (en) 2010-06-01 2015-01-27 Baxter International Inc. Process for making dry and stable hemostatic compositions
US10245348B2 (en) 2010-06-01 2019-04-02 Baxter International Inc. Process for making dry and stable hemostatic compositions
US9821025B2 (en) 2011-10-11 2017-11-21 Baxter International Inc. Hemostatic compositions
US10322170B2 (en) 2011-10-11 2019-06-18 Baxter International Inc. Hemostatic compositions
US20130096062A1 (en) * 2011-10-11 2013-04-18 Baxter Healthcare S.A. Hemostatic compositions
US9833541B2 (en) 2011-10-27 2017-12-05 Baxter International Inc. Hemostatic compositions
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
US10799611B2 (en) 2012-06-12 2020-10-13 Ferrosan Medical Devices A/S Dry haemostatic composition
US9999703B2 (en) 2012-06-12 2018-06-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US10595837B2 (en) 2013-06-21 2020-03-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
US11103616B2 (en) 2013-12-11 2021-08-31 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US11046818B2 (en) 2014-10-13 2021-06-29 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US10918796B2 (en) 2015-07-03 2021-02-16 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
CN109789091A (en) * 2016-09-14 2019-05-21 奥姆里克斯生物药品有限公司 Stable pharmaceutical foam
US11123397B2 (en) * 2016-09-14 2021-09-21 Omrix Biopharmaceuticals Ltd. Stable pharmaceutical foam
US11938165B2 (en) 2016-09-14 2024-03-26 Omrix Biopharmaceuticals Ltd. Stable pharmaceutical foam
US11801324B2 (en) 2018-05-09 2023-10-31 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Also Published As

Publication number Publication date
ES183694A1 (en) 1948-07-04
AT165549B (en) 1950-03-15
DK73956C (en) 1952-03-31
DE915973C (en) 1954-08-02
CH264752A (en) 1949-10-31

Similar Documents

Publication Publication Date Title
US2558395A (en) Undenatured gelatin hemostatic sponge containing thrombin
US2726982A (en) Hydrous gels
US2772999A (en) Hemostatic surgical compositions and dressings
US2517772A (en) Neutralized oxidized cellulose products
US3939831A (en) Process for preparing medicinal dressings
US3368911A (en) Collagen-carbonic acid surgical sponge
JPS58206751A (en) Wound covering material
US3765419A (en) Amylose acetate
US4913904A (en) Ophthalmological collagen coverings
JP2752782B2 (en) Soluble hemostatic fabric
US3238100A (en) Starch phosphate film composition and method of dressing wounds with same
US2579367A (en) Bandage
Cannon et al. Rate of epithelial regeneration: a clinical method of measurement, and the effect of various agents recommended in the treatment of burns
US2474306A (en) Cellulosic products
GB2043668A (en) Cross-linked hydroxyethyl starch
US2385262A (en) Therapeutic-anesthetic preparations
US3325366A (en) Biologically absorbable foam packing bandage and process therefor
WO2022126628A1 (en) Liquid adhesive bandage and preparation method therefor
US2914442A (en) Novel otologic preparations and the process for their preparation
CN113750287A (en) Water-soluble hemostatic sponge and preparation method thereof
DE950751C (en) Process for the production of spontaneously and rapidly absorbing tampons from absorbable material
US5128134A (en) Ophthalmological collagen coverings
JPH04500799A (en) Copolymer of vinyl acetate and vinyl alcohol crosslinked with glutaraldehyde, method for producing the same, and pharmaceuticals based on the same
SU698622A1 (en) Composition displaying hemostatic activity
RU2240813C1 (en) Method for preparing draining antibacterial wound-healing agent